COMP <GO>
USNA vs ACB // GROSS PROFIT MARGIN
USANA Health Sciences Inc. (NYSE) VS. Aurora Cannabis Inc. (NASDAQ) • 15-METRIC TALLY: USNA 1
— ACB 1
■ METRIC PARITY
LAST: $14.34 (-1.91%) • MKT CAP: $265.0M
gross-margins
78.30%
LAST: $4.08 (0.00%) • MKT CAP: $252.8M
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (USNA VS. ACB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | USNA | ACB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 78.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.90% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 2.7x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 3.22% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 4.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 1.20% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 8.30% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.56 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.3 | 50.2 | -4.90 | ACB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.9x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $265.0M | $252.8M | $12.2M | USNA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | USNA REV | ACB REV | USNA GROSS % | ACB GROSS % | USNA FCF | ACB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $925.3M | — | 78.3% | — | $8.5M | — |
| FY 2024 | $854.5M | — | 81.1% | — | $50.9M | — |
| FY 2023 | $921.0M | — | — | — | $70.6M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
USNA // BETA —
ACB // BETA —